US 7662974
Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
granted A61PA61P13/08A61P15/00
Quick answer
US patent 7662974 (Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same) held by Takeda Pharmaceutical Company Limited expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P13/08, A61P15/00, A61P17/14, A61P35/00